Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. the ROMA II trial

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3715-3720

  Sardella, Gennaro ^a   Lucisano, Luigi ^a   Mancone, Massimo ^a   Conti, Giulia ^a   Calcagno, Simone ^a   Stio, Rocco E ^a   Pennacchi, Mauro ^a   Biondi Zoccai, Giuseppe ^b   Canali, Emanuele ^a   Fedele, Francesco ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Elective coronary angioplasty; Myocardial necrosis; Statin reload

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CREATINE KINASE BB; CREATINE KINASE MM; FIBRINOGEN RECEPTOR ANTAGONIST; ROSUVASTATIN; SIMVASTATIN; TROPONIN T;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART MUSCLE NECROSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SIDE EFFECT; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

ELECTIVE CORONARY ANGIOPLASTY; MYOCARDIAL NECROSIS; STATIN RELOAD;

AGED; ANGINA, STABLE; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PYRIMIDINES; PYRROLES; SULFONAMIDES; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 84886289334     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.017     Document Type: Article

References (23)

1. R.M. Califf, A.E. Abdelmeguid, and R.E. Kunitz Myonecrosis after revascularization procedures J Am Coll Cardiol 31 1998 241 251
2. S.J. Brener, S.G. Ellis, J. Schneider, and E.J. Topol Frequency and long-term impact of myonecrosis after coronary stenting Eur Heart J 23 2002 869 876
3. A. Prasad, and J. Herrmann Myocardial infarction due to percutaneous coronary intervention N Eng J Med 364 2011 453 464
4. M. Roffi, D.P. Chew, and D. Mukherjee Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes: gradient of benefit related to the revascularization strategy Eur Heart J 23 2002 1441 1448
5. E.M. Mahoney, K. Wang, and S.V. Arnold Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38 Circulation 121 2010 71 79
6. A.W. Chan, D.L. Bhatt, and D.P. Chew Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696
7. J. Herrmann, A. Lerman, and D. Baumgart Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction Circulation 106 2002 2180 2183
8. P.H. Jones, M.H. Davidson, and M.A. Sten Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin and pravastatin across doses (STELLAR trial) Am J Cardiol 92 2003 152 160
9. S.J. Nicholls, G. Brandrup-Wognsen, M. Palmer, and P.J. Barter Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus simvastatin on lowering level of atherosclerotic lipids (from VOYAGER) Am J Cardiol 106 2010 69 76
10. G. Sardella, G. Conti, and M. Donahue ROsuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA trial Catheter Cardiovasc Interv 81 2013 E36 E43
11. K. Thygesen, J.S. Alpert, H.D. White on behalf of the joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
12. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary interventions: results of ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565
13. G. Patti, V. Pasceri, and G. Colonna Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
14. J.P.A. Ioannidis, E. Karvouni, and D.G. Katritis Mortality risk conferred by small elevations of creatine-kinase Mb isoenzyme after percutaneous intervention J Am Coll Cardiol 42 2003 1406 1411
15. K.M. Akkerhuis, J.H. Alexander, and B.E. Tardiff Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 105 2002 554 556
16. S.J. Brenner, S.G. Ellis, J. Schneider, and E.J. Topol Frequency and long-term impact of myonecrosis after coronary stenting Eur Heart J 23 2002 869 876
17. V. Pasceri, G. Patti, A. Nusca, G. Pristipino, G. Richichi, and G. Di Sciascio Randomized trial of atorvastatin for reduction of myocardial damage during percutaneous intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Circulation 110 2004 674 678
18. C. Briguori, G. Visconti, and A. Focaccio Novel approaches for preventing or limiting events (NAPLES II) trial: impact of a single high dose of atorvastatin on periprocedural myocardial infarction J Am Coll Cardiol 54 2009 2157 2163
19. S. Cay, G. Cagirci, N. Sen, Y. Balbai, T. Durmaz, and S. Aydogdu Prevention of periprocedural myocardial injury using a single high loading dose of rosuvastatin Cardiovasc Drugs Ther 24 2010 41 47
20. G. Patti, C. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention. A collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
21. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter Effect of two intense statin regimens on progression of coronary disease N Engl J Med 365 22 2011 2078 2087
22. E.S. Xenos, S.L. Stevens, L.B. Freeman, D.C. Cassada, and M.H. Goldman Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells Ann Vasc Surg 19 2005 386 392
23. A. Nusca, R. Melfi, and G. Di Sciascio Review: percutaneous coronary interventions and statins therapy Ther Adv Cardiovasc Dis 2008 101 107